Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-180,000
Closed -$14M 8306
2024
Q1
$14M Buy
+180,000
New +$13.4M ﹤0.01% 2630
2019
Q2
Sell
-30,000
Closed -$1.45M 7276
2019
Q1
$1.45M Buy
+30,000
New +$1.35M ﹤0.01% 4241
2016
Q4
Sell
-50,000
Closed -$1.94M 7148
2016
Q3
$1.94M Hold
50,000
﹤0.01% 3660
2016
Q2
$1.73M Buy
+50,000
New +$1.73M ﹤0.01% 3748
2015
Q1
Sell
-1,000
Closed -$27K 7270
2014
Q4
$27K Sell
1,000
-1,600
-62% -$41.3K ﹤0.01% 6658
2014
Q3
$63K Buy
2,600
+1,600
+160% +$40.4K ﹤0.01% 6351
2014
Q2
$25K Sell
1,000
-500
-33% -$11.7K ﹤0.01% 7069
2014
Q1
$32K Sell
1,500
-3,200
-68% -$69K ﹤0.01% 6672
2013
Q4
$105K Buy
4,700
+3,700
+370% +$81.6K ﹤0.01% 6089
2013
Q3
$21K Sell
1,000
-112,800
-99% -$2.4M ﹤0.01% 6867
2013
Q2
$2.2M Buy
+113,800
New +$2.38M ﹤0.01% 3092

Other funds holding HOLX

Bank of America's HOLX Position: Q1 2026 in Review

Bank of America reduced its Hologic (HOLX) stake by 23% in Q1 2026, selling an estimated $51.1M and leaving 2,254,024 shares worth $170M. The position accounts for 0.01% of the portfolio, ranked #814.

Bank of America first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $259M in Q3 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Bank of America held 2,254,024 shares of Hologic worth $170M as of Q1 2026.
  • Bank of America sold 680,131 Hologic shares in Q1 2026, an estimated $51.1M.
  • Hologic made up 0.01% of Bank of America's portfolio in Q1 2026, its #814 holding.
  • Bank of America first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Hologic position peaked at $259M in Q3 2024.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.